Thymoglobulin

Thymoglobulin (manufactured by sanofi) is a rabbit anti-human thymocyte immunoglobulin preparation commonly used for induction therapy in kidney and heart transplant patients.[1] It may also be used in the treatment of acute allograft rejection, particularly when corticosteroids are ineffective in reversing the rejection.[2]

References

  1. ↑ Thiyagarajan, UM; Ponnuswamy, A; Bagul, A (2013). "Thymoglobulin and its use in renal transplantation: a review.". American journal of nephrology. 37 (6): 586–601. doi:10.1159/000351643. PMID 23774740.
  2. ↑ Deeks, ED; Keating, GM (30 July 2009). "Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.". Drugs. 69 (11): 1483–512. doi:10.2165/00003495-200969110-00007. PMID 19634926.


This article is issued from Wikipedia - version of the 5/21/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.